Here, the aminotransferase (ALT)/aspartate aminotransferase (AST) ratio was used as a marker of liver function for NAFLD risk because an earlier study reported a positive association between the ALT:AST ratio (even at its normal level) and NAFLD risk [20,21]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.